Eli Lilly

Lilly announces new $4.5 billion site – the Lilly Medicine Foundry – to drive innovation in drug production and make medicines for clinical trials

Indiana facility will combine research, manufacturing and the latest technology to innovate new production methods and scale global access to clinical supply for Lilly's growing pipeline Opening in late 2027, the facility will increase Lilly's total capital commitment in the United States to more than $23 billion since 2020. 2 October 2024 -- Indiana, US -- Eli Lilly and Company today...

NICE Recommends Lilly’s Mirikizumab (OMVOH) for the Treatment of Eligible Adults with Moderately to Severely Active Ulcerative Colitis.

22 September 2023 -- Basingstoke, UK -- Eli Lilly and Company announced today that the National Institute for Health and Care Excellence (NICE) have recommended mirikizumab for the treatment of adults with moderately to severely active Ulcerative Colitis (UC) in adults when conventional or biological treatment cannot be tolerated, or the condition has not responded...
450 Kendall Street Cambridge, MA 02142

1-800-545-5979